Medexus Pharmaceuticals (MDP) AGM 2025 summary

Opening remarks and agenda

• Chair welcomed shareholders, directors, and guests, outlined meeting procedures, and confirmed voting would be conducted online with questions accepted via the platform.

• Three formal business items were presented: financial statements, election of directors, and reappointment of auditors.

Board and executive committee updates

• Chair and secretary roles were confirmed, with contingency plans for technical issues in the virtual format.

• Scrutineer appointed to oversee voting and attendance.

Financial performance review

• Consolidated financial statements for years ended March 31, 2025 and 2024, and the auditor's report were presented and made available to shareholders.

• No questions or comments were submitted regarding the financial statements.